NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED, Exams of Nursing

NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED

Typology: Exams

2022/2023

Available from 06/22/2023

Examprof
Examprof 🇺🇸

4.1

(24)

2.9K documents

1 / 11

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
NSG 550 Diagnostics Study Guide Quiz #2
Pulmonary Diagnostics Quiz #2
Pulmonary Function Tests/Spirometry
o Varies w/ age, sex, height, weight
o Used to eval: Preop eval of lungs and pulmonary reserve, response to
bronchodilator therapy, differentiate between restrictive and obstructive chronic
pulmonary disease, determine diffusing capacity of lungs, inhalation allergy
tests
o Routinely include spirometry, airflow measurement, lung volume and capacity
Forced vital capacity (FVC): Amount of air that can be forcefully expelled
from a maximally inflated lung position. Less than expected values occur
in obstructive and restrictive pulmonary diseases.
Forced expiratory volume in 1 second (FEV1): Volume of air expelled
during the first second of FVC. In obstructive pulmonary disease, airways
are narrowed and resistance to flow is high. Therefore not so much air can
be expelled in 1 second, and FEV1 is less than the predicted value. In
restrictive lung disease, FEV1 is decreased because the amount of air
originally inhaled is low, not because of airway resistance. Therefore the
FEV1/FVC ratio should be measured. In restrictive lung disease a normal
value is 80%, and in obstructive lung disease this ratio is considerably
less. The FEV1 value will reliably improve with bronchodilator therapy if
a spastic component to obstructive pulmonary disease exists. .
o Spirometry: Greater than 80% of expected value is normal
o Airflow rate: Diminished at less than 60% of normal. Increase of 20% with
bronchodilator = prescribe
o Diagnosis of COPD requires demonstration of persistent airflow limitation based
on spirometry testing, generally defined as post bronchodilator FEV1/FVC <70%.
Classification of COPD severity should be determined by the assessment of
spirometry testing at regular intervals. Some risk factors for COPD include
smoking, pollution exposure, and genetic predisposition. COPD typically has an
onset later in life and a slower progression of symptoms as compared to asthma.
Additionally, COPD has a poorer response to inhaled therapy as compared to
asthma.
Polysomnography (Sleep study)
o Indicated in any person who snores excessively; experiences narcolepsy,
excessive daytime sleeping, or insomnia; or has motor spasms while sleeping; and
in patients with documented cardiac rhythm disturbances limited to sleep time.
o Sleep apnea
o Actigraphy: Watch that can be worn a few nights at home
Bronchoscopy
o Used for performing various diagnostic and therapeutic procedures.
o Visualization of the tracheobronchial tree; transbronchial and endobronchial
biopsies; bronchoalveolar lavage; removal of foreign bodies, clots, mucus plugs;
and deployment of metallic stents. Aspiration of deep sputum, control of bleeding
pf3
pf4
pf5
pf8
pf9
pfa

Partial preview of the text

Download NSG 550 Diagnostics Study Guide Quiz #2 WELL EXPLAINED and more Exams Nursing in PDF only on Docsity!

Pulmonary

Diagnostics Quiz

  • Pulmonary Function Tests/Spirometry o Varies w/ age, sex, height, weight o Used to eval: Preop eval of lungs and pulmonary reserve, response to bronchodilator therapy, differentiate between restrictive and obstructive chronic pulmonary disease, determine diffusing capacity of lungs, inhalation allergy tests o Routinely include spirometry, airflow measurement, lung volume and capacity ▪ Forced vital capacity (FVC): Amount of air that can be forcefully expelled from a maximally inflated lung position. Less than expected values occur in obstructive and restrictive pulmonary diseases. ▪ Forced expiratory volume in 1 second (FEV1): Volume of air expelled during the first second of FVC. In obstructive pulmonary disease, airways are narrowed and resistance to flow is high. Therefore not so much air can be expelled in 1 second, and FEV1 is less than the predicted value. In restrictive lung disease, FEV1 is decreased because the amount of air originally inhaled is low, not because of airway resistance. Therefore the FEV1/FVC ratio should be measured. In restrictive lung disease a normal value is 80%, and in obstructive lung disease this ratio is considerably less. The FEV1 value will reliably improve with bronchodilator therapy if a spastic component to obstructive pulmonary disease exists.. o Spirometry: Greater than 80% of expected value is normal o Airflow rate: Diminished at less than 60% of normal. Increase of 20% with bronchodilator = prescribe o Diagnosis of COPD requires demonstration of persistent airflow limitation based on spirometry testing, generally defined as post bronchodilator FEV1/FVC <70%. Classification of COPD severity should be determined by the assessment of spirometry testing at regular intervals. Some risk factors for COPD include smoking, pollution exposure, and genetic predisposition. COPD typically has an onset later in life and a slower progression of symptoms as compared to asthma. Additionally, COPD has a poorer response to inhaled therapy as compared to asthma.
  • Polysomnography (Sleep study) o Indicated in any person who snores excessively; experiences narcolepsy, excessive daytime sleeping, or insomnia; or has motor spasms while sleeping; and in patients with documented cardiac rhythm disturbances limited to sleep time. o Sleep apnea o Actigraphy: Watch that can be worn a few nights – at home
  • Bronchoscopy o Used for performing various diagnostic and therapeutic procedures. o Visualization of the tracheobronchial tree; transbronchial and endobronchial biopsies; bronchoalveolar lavage; removal of foreign bodies, clots, mucus plugs; and deployment of metallic stents. Aspiration of deep sputum, control of bleeding

o Common clinical indications for bronchoscopy include (but are not limited to) hemoptysis, malignancy, interstitial lung disease, pulmonary infections, and pleural effusion.

  • Pleural Tap (Thoracentesis and pleural fluid analysis) o Performed to determine the cause of an unexplained pleural effusion. It is also performed to relieve the intrathoracic pressure that accumulates with a large volume of fluid and inhibits respiration. o Transudates are most frequently caused by congestive heart failure, cirrhosis, nephrotic syndrome, and hypoproteinemia. ▪ Clear/serous, protein < 3 o Exudates are most often found in inflammatory, infectious, or neoplastic conditions. ▪ Cloudy/turbid, + WBC, protein > 3, Low glucose, pleural fluid/serum LCH > 0.6, o CXR is obtained before thoracentesis to ensure that the pleural fluid is mobile and accessible to a needle placed within the pleural space.
  • Diagnosis of Influenza o RNA/DNA-PCR – Very specific. Part of respiratory virus panel o Antibody - Front-line testing, non-specific
  • Pulmonary Embolus Diagnosis and Management o Acquired Risk Factors

o Chest pain, SOB, feelings of doom, pleurodynia (pain w/ deep inhale), Tachycardia, hypoxemia, S4 gallop o Increased D-Dimer, decreased fibrinogen, V/P mismatch, low PO2 and high /low PCO2, reduce diffusion capacity, Enlarged PA on CXR, increase alveolar dead space, R ventricular dysfunction, S1Q3T3 on ECG, Pulm artery emboli on CT

  • Ventilation/Perfusion Scan o Nuclear medicine o Often used to detect PE – Will show mismatch in V/P
  • CT Scan o Diagnosing and evaluating pathologic conditions such as tumors, nodules, hematomas, parenchymal coin lesions, cysts, abscesses, pleural effusion, and enlarged lymph nodes affecting the lungs and mediastinum. Tumors and cysts of the pleura and fractures of the ribs can also be seen. When an intravenous (IV) contrast material is given, vascular structures can be identified and a diagnosis of
  • Measurement of blood pressure (criteria for diagnosis of hypertension) o Normal: <120/80 mmHg o Elevated: Systolic Blood Pressure (SBP) between 120-129 mmHg and Diastolic Blood Pressure (DBP) less than 80 mmHg o Stage 1: SBP between 130-139 mmHg or DBP between 80-89 mmHg o Stage 2: SBP at least 140 mmHg or DBP at least 90 mmHg
  • Holter Monitor o Used to record a patient’s heart rate and rhythm for 1 or more days. o Indicated in patients who experience syncope, palpitations, atypical chest pains, or unexplained dyspnea.
  • Blood Tests Used to Assess Risk for Coronary Vascular Disease: o Total Cholesterol • High-Density Cholesterol • Low-Density Cholesterol • Triglycerides • Apolipoprotein B • Lipoprotein (a) • Apolipoprotein E Genotyping - Fibrinogen • C-Reactive Protein • Homocysteine • Insulin, Fasting
  • Lipid Profile - Performed to assess the risk of coronary vascular disease o Lipoproteins are predictors of heart disease. Blood levels should be collected after a 12- to 14-hour fast. ▪ HDL is often called good cholesterol, because it removes cholesterol from the tissues and transports it to the liver for excretion. High levels are associated with a decreased risk for coronary heart disease. ▪ LDL is often called bad cholesterol, because it carries cholesterol and deposits it into the peripheral tissues. High levels are associated with an increased risk for CHD. o Cholesterol varies greatly and should be verified by repeat test. o Triglycerides are transported by LDL/VLDL and are deposited in fatty tissue when levels are high

o

  • Venous Doppler (Duplex) o Called duplex because it combines the benefits of Doppler with B-mode scanning o Used to detect DVT o Not accurate for detection of venous occlusive disease of the lower calf (venography better)

• DVT

o DVT occurs when a blood clot forms in a deep vein, usually in the lower leg, thigh, or pelvis, but sometimes it can occur in the arm o The most serious complication of DVT is when part of the clot breaks off, travels through the bloodstream to the lungs, then causing a blockage known as a pulmonary embolism o Risk factors for DVT include hospitalization, recent surgery, immobility, older age, obesity, positive family history, malignancy, estrogen-based medications (i.e., birth control and hormone replacement), pregnancy, and injury/trauma o Symptoms of DVT include swelling (usually unilateral), pain, tenderness, and redness over the affected area o The standard diagnostic test for diagnosing a DVT is the venous duplex ultrasound study. It can detect blockages or clots in the deep veins. Other diagnostic tests for DVT include D-dimer blood test, MRI, and CT scan o Treatments for DVT usually include anticoagulants, thrombolytics, and placement of inferior vena cava filters. Providers should also try to eliminate the causative factor. Compression stockings are often encouraged

  • Arterial Doppler o Single-mode arterial Doppler studies - peripheral arteriosclerotic occlusive disease of the extremities can be easily located. By slowly deflating blood pressure cuffs placed on the calf and ankle, systolic pressure in the arteries of the extremities can be accurately measured by detecting the first evidence of blood flow with the Doppler transducer. The extremely sensitive Doppler ultrasound detector can recognize the swishing sound of even the most minimal blood flow. Normally systolic blood pressure is slightly higher in the arteries of the arms than in the legs. If the difference in blood pressure exceeds 20 mm Hg, occlusive disease is believed to exist immediately proximal to the area tested. Lower extremity arterial bypass graft patency can also be assessed with Doppler ultrasound.
  • Ankle/Brachial Index o Arterial plethysmography is performed by applying three blood pressure cuffs to the proximal, middle, and distal parts of an extremity. Pressure readings are also taken in the upper arm (brachial) artery. These are then attached to a pulse volume recorder (plethysmograph) that enables each pulse wave to be displayed. A reduction in amplitude of a pulse wave in any of the three cuffs indicates arterial occlusion immediately proximal to the area where the decreased amplitude is noted. Also, measurements of arterial pressures are performed at each cuff site. A difference in pressure of greater than 20 mm Hg indicates a degree of arterial occlusion in the extremity. A positive result is reliable evidence of arteriosclerotic peripheral vascular occlusion. However, a negative result does not definitely exclude this diagnosis, because extensive vascular collateralization can compensate for even a complete arterial occlusion. o An Ankle/Brachial Ratio of <0.9 indicates peripheral vascular disease in the lower extremity. Arterial plethysmography can also be performed immediately after exercise to determine if symptoms of claudication are caused by peripheral vascular occlusive disease.

recorded. An ultrasound doppler device is utilized to amplify the sound of arterial blood flow in the brachial, dorsalis pedis, and posterior tibial pulses. The test is usually performed with the patient in a supine position. A healthy ABI is 1.00 or greater; if the ABI is less than 0.90 at rest, PAD may be suspected. An ABI less the 0.40 indicates severe PAD o Treatments for PAD often include antiplatelet medications, statins, anti-HTN medications, angioplasty, arterial bypass surgery, and modification of risk factors o Peripheral venous disease ▪ swelling of the legs or ankles (edema) ▪ pain that gets worse when you stand and gets better when you raise your legs ▪ leg cramps ▪ aching, throbbing, or a feeling of heaviness in your legs ▪ itchy legs ▪ weak legs ▪ thickening of the skin on your legs or ankles ▪ skin that is changing color, especially around the ankles ▪ leg ulcers ▪ varicose veins ▪ a feeling of tightness in your calves

  • Echocardiogram (US – all kinds) o Performed to evaluate heart wall motion (a measure of heart wall function) and to detect valvular disease, evaluate the heart during stress testing, and identify and quantify pericardial fluid. o Used in ER for chest pain o Used to diagnose pericardial effusion, valvular heart disease (eg, mitral valve prolapse, stenosis, regurgitation), subaortic stenosis, myocardial wall abnormalities (eg, cardiomyopathy), infarction, aneurysm, and cardiac tumors (eg, myxomas). Atrial and ventricular septal defects and other congenital heart diseases, and postinfarction mural thrombi are also recognized with this testing. o Can be done transesophageal (useful in COPD because air gets in way)
  • Cardiac Stress Test o Eval for CAD in angina, intermittent claudication, evaluate treatment and safe exercise limits o Exercise, chemical or pacer stress o EKG, heart rate and BP usually but echo and nuclear scan can also be used
  • Arteriography/Venography o Injecting dye and taking x-rays to see vasculature

GI

  • CT of abdomen/pelvis o Used in evaluating the abdominal organs and pelvis. CT can be used to guide needles during biopsy of tumor and aspiration of fluid, in staging known neoplasms, and to monitor abdominal disease when serially and repeatedly performed
  • Diverticulitis:

o Diverticulosis occurs when small pouches form and push outward through weak spots in the wall of the colon, most commonly the sigmoid colon o Diverticulitis occurs when one or a few of these pouches become inflamed and/or infected o Symptoms of Diverticulitis often include: ▪ Severe pain, typically in the lower left side of the abdomen ▪ Nausea and/or vomiting ▪ Constipation or diarrhea ▪ Fever and chills o Diagnostic Tests for Diverticular Disease (in order of importance) include: ▪ CT Scan of abdomen and pelvis ▪ Blood tests to rule out infection (CBC) ▪ Colonoscopy ▪ Lower GI series, also known as a barium enema o Treatments often include: ▪ High fiber diet and/or fiber supplements ▪ Probiotics ▪ If infection is noted (i.e. diverticulitis)- bowel rest, liquid diet, antibiotics ▪ Severe cases may require colon resection surgery

  • Acute Pancreatitis: o Pancreatitis is inflammation of the pancreas. Acute pancreatitis occurs suddenly and is usually short-term. Approximately 275,000 hospital stays occur in the United States each year for acute pancreatitis o Risk factors include: male gender, African American race, positive family history of pancreatitis, diabetes mellitus, elevated triglycerides, cystic fibrosis, gallstones, obesity, alcohol abuse, and cigarette smoking o Symptoms include: ▪ Severe pain in the epigastric (upper) area of the abdomen, often radiates to the back or can be in the left upper quadrant ▪ Fever ▪ Nausea and/or vomiting ▪ Swollen or tender abdomen on palpation ▪ Tachycardia o Diagnostic Tests often include: ▪ Blood Tests - Amylase and Lipase (usually elevated) - Lipid Profile (usually elevated) - Blood Glucose (usually elevated due to impaired beta cell function) - CBC (to assess for infectious processes) ▪ Imaging - Pancreatic and/or gallbladder ultrasound - CT Scan o Treatments often include: ▪ Bowel Rest, IV hydration (if hospitalized) ▪ Pain medicine

o Recommended for patients who have had a change in bowel habits or obvious or occult blood in the stool or who have abdominal pain. It is also used as a surveillance tool for patients who have had colorectal cancer, inflammatory bowel disease, or polyposis. o Virtual done with CT

  • Flexible sigmoidoscopy o Up to 60cm from anus
  • Colorectal Cancer Screening Guidelines: o Screening for colorectal cancer is recommended starting at age 50 years and should continue until age 75 years o The decision to screen for colorectal cancer in patients aged 76 to 85 years should be an individual decision, taking into account the patient’s state of health and prior screening history o There are several different screening tests to detect early-stage colorectal cancer including: ▪ Fecal Occult Blood Testing- completed annually ▪ Colonoscopy- completed every ten years ▪ Flexible Sigmoidoscopy- completed every five years ▪ Fecal Immunochemical Test (FIT)- completed annually ▪ Fecal Immunochemical Test + DNA (FIT-DNA) - completed every one to three years
  • Upper endoscopy o Procedure used to visualize the upper digestive system using a tiny camera attached the end of a long, flexible tube. Upper endoscopy can be used to diagnose and treat conditions of the esophagus, stomach, and duodenum ▪ Investigate symptoms such as nausea, vomiting, abdominal pain, dysphagia (difficulty swallowing), and GI bleeding ▪ Collect biopsy of tissues in the upper GI tract ▪ Complete minor procedures such as burning a blood vessel, widening a narrow esophagus, or removing a polyp or a foreign object
  • Barium swallow x-ray o Identifies swallowing/esophageal abnormalities o Provides visualization of the lumen of the esophagus. It is indicated in patients with the following symptoms: • Dysphagia • Noncardiac chest pain • Painful swallowing • Swallowing abnormalities • Gastroesophageal reflux
  • Testing for H. Pylori o Indicated in patients who are suspected of having peptic ulcers (active or past history), gastric MALT lymphoma, melena, hematemesis, weight loss, persistent vomiting, dysphagia, or anemia. o Culture – takes a week but give antibiotic sensitivities o Biopsy – also takes time o Rapid Urease testing – piece of gastric mucosa used, results in 3 hours o Breath for urea – may be first line, expensive but reliable

o Serology – IgG or IgM - least sensitive o Stool test - ELISA to monitor for eradication after treatments

  • Cholecystitis o Symptoms of cholecystitis: ▪ Painful episodes associated with nausea and vomiting following “heavy” meals ▪ Scleral icterus ▪ Marked right upper quadrant (RUQ) and epigastric tenderness to palpation (Murphy’s sign). o Pancreatitis usually presents as LUQ tenderness with or without epigastric pain. o The gallbladder is located in the RUQ; therefore, cholecystitis typically presents as RUQ tenderness with or without epigastric pain. o Because this patient also presents with scleral icterus (i.e. jaundice), it is important to rule out a blockage in the common bile duct or the pancreatic duct. In order to assess the patency of these ducts, an endoscopic retrograde cholangiopancreatography (ERCP) should be ordered and completed. The ERCP combines an upper gastrointestinal endoscopy with x-rays to visualize and treat problems of the bile and pancreatic ducts